Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5′-diphosphate in human platelets
- 15 March 1994
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 47 (6) , 1013-1018
- https://doi.org/10.1016/0006-2952(94)90412-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Effects of purines on the longitudinal muscle of the rat colonBritish Journal of Pharmacology, 1992
- Effects of the P2‐purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5′‐diphosphateBritish Journal of Pharmacology, 1992
- Characterization of the P1‐purinoceptors mediating contraction of the rat colon muscularis mucosaeBritish Journal of Pharmacology, 1992
- Suramin is a slowly‐equilibrating but competitive antagonist at P2x‐receptors in the rabbit isolated ear arteryBritish Journal of Pharmacology, 1990
- Suramin antagonizes responses to P2‐purinoceptor agonists and purinergic nerve stimulation in the guinea‐pig urinary bladder and taenia coliBritish Journal of Pharmacology, 1990
- Suramin and the inhibitory junction potential in taenia caeci of the guinea-pigEuropean Journal of Pharmacology, 1989
- The inhibitory action of suramin on the P2-purinoceptor response in smooth muscle cells of guinea-pig taenia caeciEuropean Journal of Pharmacology, 1989
- Suramin: a reversible P2‐purinoceptor antagonist in the mouse vas deferensBritish Journal of Pharmacology, 1988
- Extracellular ATP: effects, sources and fateBiochemical Journal, 1986
- Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV InfectionThe Journal of Clinical Pharmacology, 1986